The Clinical, Genetic, and Single-Cell Landscape of Birt-Hogg-Dubé Syndrome: A Study of 85 Chinese Families

Birt-Hogg-Dubé syndrome is a rare genetic condition that runs in families, causing the body to grow unusual cysts in the lungs, bumps on the skin, and tumors in the kidneys. For decades, doctors have known that the root cause lies in a broken instruction manual within our DNA, specifically in a gene called FLCN. This gene normally acts as a safety switch, helping cells know when to stop growing and how to stick together to form healthy tissue. When this switch is broken, the lungs can develop thin-walled pockets of air that may burst, leading to a collapsed lung. While researchers have studied this condition extensively in European and North American populations, the picture has remained blurry for people of Asian descent, who often show different symptoms. Furthermore, scientists have long wondered exactly how a single broken gene inside a cell leads to the large, visible holes that appear in the lung tissue.

A team of researchers at the First Affiliated Hospital of Guangzhou Medical University has now filled in these gaps by studying 85 families in southern China. They gathered detailed medical records from 107 patients and, for the first time, peered inside the lung tissue of four of these patients using a powerful new technology called single-cell RNA sequencing. This technique allows scientists to read the genetic activity of thousands of individual cells at once, revealing what each cell is doing rather than just looking at the tissue as a whole. Their work uncovers a distinct pattern of mutations unique to this population and identifies a specific type of misbehaving cell that appears to drive the formation of lung cysts.

The study began by looking at the clinical stories of 107 patients from 85 different families. The researchers found a striking difference between these Chinese patients and the European groups described in previous literature. While the European patients often developed skin bumps and kidney tumors alongside their lung issues, the Chinese patients in this study almost exclusively suffered from lung problems. Nearly all of them had cysts in their lungs, and more than three-quarters had experienced a collapsed lung at some point. In contrast, skin bumps were found in only a tiny fraction of the group, and kidney tumors were rare. This suggests that the same genetic error can manifest very differently depending on a person's background.

When the team examined the genetic code of these patients, they discovered that the broken instructions were not random. They found that the mutations clustered in specific spots on the FLCN gene, with three particular errors appearing most frequently. One of these errors, a small insertion of genetic material, was the most common in their group, differing from the most common error seen in European studies. The researchers also identified 26 completely new mutations that had never been reported before, expanding the known map of how this disease can arise. By comparing the specific genetic errors to the symptoms, they found a potential link: the few patients who did have skin bumps happened to carry a specific mutation that was also common in European patients, hinting that the type of genetic break might influence which organs are affected.

To understand how these broken genes actually cause holes in the lungs, the researchers turned to the single-cell sequencing data. They compared lung tissue from four patients with the condition against healthy lung tissue. The analysis revealed that the lung environment in these patients was in a state of chaos. The normal cells that line the air sacs and keep them open were disappearing, while other cells, such as immune fighters and scar-forming fibroblasts, were multiplying and taking over. The tissue was no longer a quiet, organized structure but a noisy, active battlefield where cells were constantly signaling each other to change and repair.

The most significant discovery was the identification of a strange, hybrid cell population that existed only in the diseased lungs. The researchers named these "Epi-EMT-like" cells because they looked like a confusing mix of two different cell types. Normally, lung cells are either epithelial cells, which form the lining of the air sacs, or mesenchymal cells, which provide structural support. These hybrid cells, however, were expressing the genetic markers of both types simultaneously. They had lost their identity as stable lung lining cells and were starting to act like mobile, scar-forming cells. The data suggests that these cells likely originate from the normal air-sac lining cells, which, under the influence of the broken gene, begin to transform incorrectly.

These hybrid cells were not just changing on their own; they were actively disrupting their surroundings. They were sending out strong chemical signals that recruited immune cells and fibroblasts, creating a cycle of inflammation and tissue remodeling. The researchers observed that the normal connections between cells were breaking down, and the cells were losing their ability to stick together firmly. This loss of structural integrity, combined with the constant pressure of breathing, likely causes the thin walls of the air sacs to weaken, stretch, and eventually rupture, forming the characteristic cysts. The study suggests that the disease is not caused by a single cell type failing, but by a complex conversation between different cells that goes wrong, leading to the physical breakdown of the lung architecture.

This research provides the first clear look at the genetic and cellular landscape of Birt-Hogg-Dubé syndrome in a large Chinese population, confirming that the disease behaves differently across ethnic groups. By identifying the specific hybrid cells that drive the formation of lung cysts, the study offers a new target for understanding the disease. While the findings are based on a limited number of lung samples and require further confirmation, they shift the focus from simply observing the symptoms to understanding the cellular machinery that causes them. This deeper understanding could eventually help doctors develop treatments that stop the cells from transforming and the lungs from breaking down, moving beyond managing the symptoms to addressing the root cause of the condition.